| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antifungal prophylaxis with azole derivatives
|
Castagnola, E.
|
|
2004
|
10 |
S1 |
p. 86-95
10 p.
|
artikel
|
| 2 |
History of the development of azole derivatives
|
Maertens, J.A.
|
|
2004
|
10 |
S1 |
p. 1-10
10 p.
|
artikel
|
| 3 |
Human fusariosis
|
Dignani, M.C.
|
|
2004
|
10 |
S1 |
p. 67-75
9 p.
|
artikel
|
| 4 |
Infections due to emerging and uncommon medically important fungal pathogens
|
Walsh, T.J.
|
|
2004
|
10 |
S1 |
p. 48-66
19 p.
|
artikel
|
| 5 |
Introduction
|
Nord, Carl Erik
|
|
2004
|
10 |
S1 |
p. vi-
1 p.
|
artikel
|
| 6 |
Invasive infections caused by Blastoschizomyces capitatus and Scedosporium spp.
|
Bouza, E.
|
|
2004
|
10 |
S1 |
p. 76-85
10 p.
|
artikel
|
| 7 |
Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment
|
Prabhu, R.M.
|
|
2004
|
10 |
S1 |
p. 31-47
17 p.
|
artikel
|
| 8 |
New clinical presentations of invasive aspergillosis in non-conventional hosts
|
Paterson, D.L.
|
|
2004
|
10 |
S1 |
p. 24-30
7 p.
|
artikel
|
| 9 |
Oral versus intravenous therapy in the treatment of systemic mycosis
|
Perea, J.R. Azanza
|
|
2004
|
10 |
S1 |
p. 96-106
11 p.
|
artikel
|
| 10 |
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida
|
Pfaller, M.A.
|
|
2004
|
10 |
S1 |
p. 11-23
13 p.
|
artikel
|
| 11 |
Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity
|
Donnelly, J.P.
|
|
2004
|
10 |
S1 |
p. 107-117
11 p.
|
artikel
|
Tijdschrift beschrijving